Sort   by:  
 Page size 
UnknownChange of renal function after short-term use of cardioprotective agents in patients with type 2 diabetes is not accurately assessed by the change of estimated glomerular filtration rate: an observational study.
Not available
S-EPMC9306160 | biostudies-literature
UnknownDeterminants of arterial stiffness in patients with type 2 diabetes mellitus: a cross sectional analysis.
Not available
S-EPMC10238522 | biostudies-literature
UnknownValidation of semi-automated flow-mediated dilation measurement in healthy volunteers.
Not available
S-EPMC7331823 | biostudies-literature
UnknownA randomized, controlled, 12-month trial on the effects of an interdisciplinary treatment approach in ESRD patients: study protocol of the smart and fit for kidney transplantation trial (S&F4KTx).
Not available
S-EPMC12369097 | biostudies-literature
UnknownHow does empagliflozin improve arterial stiffness in patients with type 2 diabetes mellitus? Sub analysis of a clinical trial.
Not available
S-EPMC6440009 | biostudies-literature
UnknownEffects of treatment with SGLT-2 inhibitors on arginine-related cardiovascular and renal biomarkers.
Not available
S-EPMC8740418 | biostudies-literature
UnknownSkin sodium content as a predictor of blood pressure response to renal denervation.
Not available
S-EPMC10838764 | biostudies-literature
UnknownBlood pressure reduction after renal denervation in patients with or without chronic kidney disease.
Not available
S-EPMC10768756 | biostudies-literature
UnknownEffects of the sodium-glucose cotransporter 2 inhibitor empagliflozin on vascular function in patients with chronic heart failure.
Not available
S-EPMC8712907 | biostudies-literature
UnknownAngiotensin pathways under therapy with empagliflozin in patients with chronic heart failure.
Not available
S-EPMC10192237 | biostudies-literature
Sort   by:  
 Page size